Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04208828 · ClinicalTrials.gov registry record
IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy
A clinical trial of Gastroparesis and Neuropathy, sponsored by University of Louisville.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT04208828 is a study of Gastroparesis and Neuropathy that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 400 participants, above the 293-participant average among 44 other Gastroparesis trials with a reported enrollment target (37% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04208828, a study of Gastroparesis and Neuropathy, is actively recruiting participants, sponsored by University of Louisville.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients with the symptoms of generalized GI dysmotility, including gastroparesis, are sometimes refractory to available medications, devices and other interventions/ Some of these patients have serologic and/or endo organ abnormalities and findings consistent with autoimmune neuropathies, primarily involving the GI tract. These disorders have been known as autoimmune gastrointestinal neuropathies (GAIN) or also as autoimmune gastrointestinal dysmotility (AGID), among other terms. Some patients respond to intravenous immunoglobulin (IVIG) and this study, which is an observational clinical series, documents the patients, their findings and standardized responses to therapy with IVIG.
Conditions Studied
Study Locations (1)
Kentucky
- University of Louisville - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2020-01-02 |
| Est. Completion | 2028-01-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04208828
The ClinicalTrials.gov registry entry for NCT04208828 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 293-participant average among 44 other Gastroparesis trials with a reported enrollment target (37% higher). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Gastroparesis appearing as the primary indexed condition, and to 0 interventions.
NCT04208828 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT04208828 about?
NCT04208828 is a clinical study titled "IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy". Patients with the symptoms of generalized GI dysmotility, including gastroparesis, are sometimes refractory to available medications, devices and other interventions/ Some of these patients have serologic and/or endo organ abnormalities and findings consistent with autoimmune neuropathies, primarily...
What is the current status of trial NCT04208828?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2020-01-02. Estimated completion is 2028-01-02.
What conditions does trial NCT04208828 study?
This clinical trial studies the following conditions: Gastroparesis, Neuropathy, Gastrointestinal Motility Disorder.
Who is sponsoring clinical trial NCT04208828?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04208828 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gastroparesis Registry 4
RECRUITING
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Study of Gastric Motility in Eosinophilic Gastritis
RECRUITING
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.